Navigation Links
Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke

in improving carotid stenting outcomes," said Chuck Foltz, vice president, Abbott Vascular. "We are proud of our leadership in carotid stenting trials, with more than 10,000 patients enrolled in Abbott trials in the United States. These studies demonstrate that carotid stenting is making a difference in the lives of patients."

New Study Evaluates Next-Generation Embolic Protection Device

Abbott's next-generation Emboshield PRO(TM) Embolic Protection System, currently available in Europe, is under safety and effectiveness evaluation in PROTECT, a new U.S. clinical trial which recently began enrolling patients. The study will include 320 high surgical risk patients at 50 U.S. clinical sites. Patients will be evaluated at 30 days following stent placement to gather safety and efficacy data to support a 510(k) application to the U.S. Food and Drug Administration (FDA) for Emboshield PRO.

About Carotid Artery Disease and Stroke

Stroke is the third leading cause of death in the United States and the number one cause of disability in adults, according to the American Heart Association. Approximately 25 percent of strokes are caused by carotid artery disease. Clogged carotid arteries in the neck can cause ischemic stroke, the most common type. More than 700,000 Americans will have new (500,000) or recurrent (200,000) strokes each year, and more than 150,000 will die.

About Carotid Stenting

Carotid artery stenting is a minimally invasive treatment option for patients who require intervention and who are at high risk for complications from carotid endarterectomy, an invasive surgical procedure. Carotid artery stenting is performed by delivering a stent on a catheter through the femoral artery in the groin. The catheter is maneuvered through the patient's vasculature to the carotid artery. The stent, which is designed to prevent arterial plaque and debris from breaking off and blocking blood flow to the brain, is then expanded at the
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
8. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
9. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:12/19/2014)... Since last month,s FBI shutdown of online drug marketplace ... online black market for illegal drugs - Evolution Marketplace ... drugs and other illegal items.  New numbers from the ... lowering the numbers of drugs and illegal items available ... But some new sites that have emerged as potentially ...
(Date:12/19/2014)... and LYON, France , ... LLY ) and Adocia (Euronext Paris: FR0011184241 ... on developing an ultra-rapid insulin, known as BioChaperone Lispro, ... 2 diabetes. BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® ... Lilly and Adocia will develop BioChaperone Lispro with ...
(Date:12/17/2014)... , Dec. 17, 2014 Royal Philips ... Corporation (NASDAQ: VOLC ), a global leader in ... that they have entered into a definitive merger agreement. Pursuant ... acquire all of the issued and outstanding shares of Volcano ... price of USD 1 billion (approx. EUR 800 million), to ...
Breaking Medicine Technology:Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... , NEW YORK, Dec. ... research report is available in its catalogue: , ... 2014: Policy environment, market analysis, forecasts and growth ... , The $28.8bn Latin American market ...
... , LAKE FOREST, Ill., Dec. 1 RoundTable ... on the health-care industry, announced today that it has ... its portfolio companies, Ascent Healthcare Solutions ("Ascent") to Stryker ... companies, for $525 million in cash. Prior to ...
Cached Medicine Technology:Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 2Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 3Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 4Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 5Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 6Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 7Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities 8RoundTable Healthcare Partners Announces Sale of Ascent Healthcare Solutions to Stryker Corporation 2
(Date:12/21/2014)... Coral Gables, FL (PRWEB) December 21, 2014 ... of head lice, who do they call? The new answer ... Leon Blvd, Coral Gables FL 33134, their newest treatment center ... eradicate this pest quickly, conveniently and without the use of ... Grand Opening is scheduled for January 1, 2015. Like the ...
(Date:12/21/2014)... NY (PRWEB) December 21, 2014 The ... 1,400 in a consolidated litigation underway in New Jersey, ... a total of 1,375 claims involving the birth control ... Court. These lawsuits were filed by women who allege ... have led to uterine perforations and other complications they ...
(Date:12/21/2014)... Portland, OR (PRWEB) December 21, 2014 ... discussing some of the issues and systemic barriers for ... ITU World Paratriathlon Champion. Scheidies has a condition called ... over time. He describes how he adapted his athletic ... to use his success in triathlon to pioneer the ...
(Date:12/21/2014)... Virginia (PRWEB) December 21, 2014 Concept Plus, ... and engineering firm headquartered in Fairfax, VA., today announced ... of its Fast 50 list, which ranks the fastest growing ... rate from 2009 to 2013. , This is the first ... and it ranked # 20 with a 95.92% compound annual ...
(Date:12/20/2014)... New York, NY (PRWEB) December 20, 2014 ... with the healthcare sector have benefited the Massage ... Given the discretionary characteristics of industry products, the anticipated ... the five-year period has provided consumers with the means ... adults that have received a massage in a given ...
Breaking Medicine News(10 mins):Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... Jan. 24 (HealthDay News) -- People with chronic obstructive pulmonary ... die from cardiovascular disease or other conditions that are not ... suggests that doctors need to be more aware of these ... is known. In recent years, the average age of ...
... Ky. (Jan. 24, 2011) - Linda J. Van Eldik, director ... been awarded a $750,000 grant to further her research into ... the Edward N. And Della L. Thome Memorial Foundation, and ... Discovery Research to be given in the U.S. in 2010. ...
... SUNDAY, Jan. 23 (HealthDay News) -- Yoga may be becoming ... People have been practicing yoga for millennia to improve their ... philosophy have kept the exercise discipline firmly within the realm ... scientific evidence is building the case that the spiritual balance ...
... Reporter , MONDAY, Jan. 24 (HealthDay News) -- The anti-estrogen ... ago may also reduce the risk of dying from lung ... Jan. 24 online edition of the journal Cancer , ... women who already had breast cancer. However, the results ...
... the Indiana University School of Medicine and the Regenstrief ... women are screened for chlamydia at a significantly higher ... rates may contribute to nationwide reporting of higher rates ... The research, which used data from more than ...
... This release is available in ... scientist Dr. Timothy Geary received a $1-million grant today ... derived from African biodiversity. Grand Challenges Canada, Canada,s ... Research and the Bill & Melinda Gates Foundation have ...
Cached Medicine News:Health News:Increasingly, Other Ailments Prove Fatal for People With COPD 2Health News:Yoga's Spiritual Balance May Boost Health 2Health News:Yoga's Spiritual Balance May Boost Health 3Health News:Breast Cancer Drug May Also Help Lung Cancer Patients 2Health News:Young minority women screened at higher rate for chlamydia than young white women 2Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 2Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 3
... closed system for performing fast, clean, safe ... system is microprocessor controlled to automatically spin ... one minute. At the end of the ... across the viewing area for microscopic analysis.,The ...
... establish temporary internal drainage from the ureteropelvic ... Non-radiopaque ink bands serve as a visual ... where the coil(s) will form as he/she ... packages. Intended for one-time use. CAUTION: Periodic ...
... Used for temporary ... ureteropelvic junction to the ... Supplied sterile in peel-open ... use. CAUTION: Periodic evaluation ...
... temporary internal drainage from the ... Supplied sterile in peel-open packages. ... Periodic evaluation is advised; polyurethane, ... not remain indwelling more than ...
Medicine Products: